Olfactory Measures as Predictors of Conversion to Mild Cognitive Impairment and Alzheimer's Disease.

Published in: Brain sciences (2021)

Olfactory biomarkers show real promise as non-invasive indicators of prodromal AD. The results support the value of combining olfactory measures in assessment of risk for conversion to MCI and to AD.

Keyphrases

mild cognitive impairment
cognitive decline
parkinson disease
big data
artificial intelligence
clinical evaluation